Pfizer Invites Public To View And Listen To Webcast Of May 3 Conference Call With Analysts
http://ih.advfn.com/p.php?pid=nmona&article=47171657&symbol=PFE
Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, May 3, 2011. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s First Quarter 2011 Performance Report, to be issued that morning.
To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com and click on the “Pfizer Quarterly Corporate Performance – First Quarter 2011” link in the Investor Presentations section located on the lower right-hand corner of that page. Information on accessing and pre-registering for the webcast will be available at www.pfizer.com beginning today. Participants are advised to pre-register in advance of the conference call.
You can also listen to the conference call by dialing either 866-246-2545 in the United States and Canada or 706-634-2365 outside of the United States and Canada. The password is “First Quarter Earnings”.
Visitors to www.pfizer.com will be able to view and listen to an archived copy of the webcast of the conference call.
http://ih.advfn.com/p.php?pid=nmona&article=47171657&symbol=PFE
Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, May 3, 2011. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s First Quarter 2011 Performance Report, to be issued that morning.
To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com and click on the “Pfizer Quarterly Corporate Performance – First Quarter 2011” link in the Investor Presentations section located on the lower right-hand corner of that page. Information on accessing and pre-registering for the webcast will be available at www.pfizer.com beginning today. Participants are advised to pre-register in advance of the conference call.
You can also listen to the conference call by dialing either 866-246-2545 in the United States and Canada or 706-634-2365 outside of the United States and Canada. The password is “First Quarter Earnings”.
Visitors to www.pfizer.com will be able to view and listen to an archived copy of the webcast of the conference call.
Recent PFE News
- European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors • Business Wire • 05/13/2026 10:45:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/12/2026 09:05:04 PM
- Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant) • GlobeNewswire Inc. • 05/12/2026 11:00:00 AM
- The Next Generation of the GLP-1 Revolution Is Already Underway • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- The Next Generation of the GLP-1 Revolution Is Already Underway • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/05/2026 08:42:09 PM
- Pfizer tops Q1 expectations on growth from newer products • IH Market News • 05/05/2026 03:05:10 PM
- Wall Street Set for Rebound as Oil Prices Retreat Sharply: Dow Jones, S&P, Nasdaq, Futures • IH Market News • 05/05/2026 01:19:45 PM
- Wall Street Poised for Gains as Oil Prices Retreat: Dow Jones, S&P, Nasdaq, Futures • UK Market News • 05/05/2026 01:19:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2026 11:03:03 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 11:01:20 AM
- Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance • Business Wire • 05/05/2026 10:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 08:20:12 PM
- Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma • Business Wire • 04/29/2026 10:45:00 AM
- Pfizer Reaches Three Settlement Agreements for VYNDAMAX • Business Wire • 04/28/2026 02:17:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:40:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:39:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:37:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:37:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:37:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:37:54 PM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 04/27/2026 10:23:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:22:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:22:30 PM

